tradingkey.logo

ICU Medical Inc

ICUI
View Detailed Chart

131.710USD

-1.310-0.98%
Close 09/19, 16:00ETQuotes delayed by 15 min
3.25BMarket Cap
LossP/E TTM

ICU Medical Inc

131.710

-1.310-0.98%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.98%

5 Days

+1.02%

1 Month

+6.42%

6 Months

-12.92%

Year to Date

-15.12%

1 Year

-27.34%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
39 / 207
Overall Ranking
95 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 6 analysts
Buy
Current Rating
177.800
Target Price
+33.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 58.43.
Undervalued
The company’s latest PE is -87.09, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 25.98M shares, decreasing 7.15% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.65M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.36.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Ticker SymbolICUI
CompanyICU Medical Inc
CEOMr. Vivek Jain
Websitehttps://www.icumed.com/
KeyAI